Vancouver, British Columbia–(Newsfile Corp. – April 29, 2021) – Lobe Sciences Ltd. (“ Lobe” or the “Company“) (CSE: LOBE) (OTC Pink: GTSIF) is pleased to announce the filing of a key Patent Cooperation Treaty (“PCT”) application entitled Methods, Compositions and Devices for Treating Mild Traumatic Brain Injury, Post Traumatic Stress Disorder and Mild Traumatic Brain Injury with Post Traumatic…


Previous articleBetterLife Files Patent for Invention of Novel Subcutaneous Implant to Prevent Drug Diversion of LSD and Other Psychedelic Drugs
Next articleBexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation